Abstract
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Slow but favourable growth
In 2006, OTC healthcare sales in Australia continued to grow steadily, despite some cough, cold and allergy remedies switching from S2 to S3 classification. The key factors that led to growth in sales were the rising obesity numbers, the increase in the number of babies, the growing ageing population, increasingly stressful lifestyles leading to self-medication for prevention purposes and the weather as an unforeseeable factor. In addition, with the increase in advertising campaigns, such as the use of media and the internet to educate the public, and the stricter regulatory regime against exaggerating claims for products, consumers are now aware of the products that are suitable and offered with more choices as well as tools to help self-medicate.
Vitamins and dietary supplements still the biggest OTC healthcare sector
Vitamins and dietary supplements continued to account for the biggest share in OTC healthcare sales over the review period. Vitamins and dietary supplements grew in 2006, helped by another strong performances by glucosamine. Over the forecast period, vitamins and dietary supplements sales will continue to increase based on key factors such as prevention being better then cure. More people want to remain healthy and one of the options for doing this is to take natural healthcare products.
Symbion Health Ltd the leader in OTC healthcare
In 2006, Symbion Health Ltd was the leading player in OTC healthcare in Australia, following closely by Pfizer ESP Pty Ltd and Blackmores Ltd. Symbion Health Ltd was established after the demerger of Mayne Group Ltd in 2005. The split involved the global pharmaceutical business (Mayne Pharma) and the domestic healthcare business (Mayne Diagnostic Services, Mayne Pharmacy and Mayne Consumer Products). Blackmores Ltd trailed Symbion Health Ltd in OTC healthcare in vitamins and dietary supplements, which make up a large portion of OTC healthcare sales. No single companies had emerged to monopolise OTC healthcare, despite the trend of mergers and acquisitions that is ongoing among several big pharmaceutical companies, such as Pfizer' s sale of its OTC medication division to Johnson & Johnson in the global pharmaceutical business.
Private label affecting OTC healthcare sales
Private label is gaining value sales in the majority of the OTC healthcare sectors, particularly in analgesics, cough, cold and allergy remedies, digestive remedies, medicated skin care and vitamins and dietary supplements. The strong increase could be due to the major expansion by pharmaceutical companies in retail. Another factor contributing to the increase could be that consumers are switching to private label owing to the fact that private label offers value for money, providing the same effective treatment, but at a lower price. Private label has a negative impact on smaller companies, affecting values sales of these smaller companies.
Steady but not spectacular forecast period performance expected
Over the forecast period sales of OTC healthcare products will continue to experience flat growth. The main activities undertaken by manufacturers in OTC healthcare will focus on advertising to generate sales as well as to educate the public about products and brands. More new innovative products will emerge in the future. Players that are currently in OTC healthcare could look into potential growth areas within the market while players from other areas might enter OTC healthcare, making for a more competitive environment moving forward. Generics will expand in the next few years as more patented medicines expire. Price competition will remain in the limelight as the competitive environment heats up.
Table of Contents
- OTC HEALTHCARE IN AUSTRALIA : MARKET INSIGHT
- EXECUTIVE SUMMARY
- Slow but favourable growth
- Vitamins and dietary supplements still the biggest
- OTC healthcare sector
- Symbion Health Ltd the leader in OTC healthcare
- Private label affecting OTC healthcare sales
- Steady but not spectacular forecast period performance expected
- KEY TRENDS AND DEVELOPMENTS
- Expansion of pharmacy banner groups
- Drivers of OTC healthcare innovation products
- Merger and acquisition focus for expansion
- Direct sellers/Internet to change the face of OTC healthcare
- PBS reform to lower the prices of medicines for patients
- Illnesses related to stress and bad diet
- MARKET INDICATORS
- Table 1 Life Expectancy at Birth 2001-2006
- MARKET DATA
- Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
- Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
- Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
- Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
- Table 6 Penetration of Private Label by Sector 2002-2006
- Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
- Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
- Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
- Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
- APPENDIX
- OTC Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Generics
- Consumer Expenditure on Health Goods and Medical Services
- Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
- DEFINITIONS
- Sources
- Summary 1 Research Sources
- LOCAL COMPANY PROFILES - AUSTRALIA
- AUSTRALIAN PHARMACEUTICAL INDUSTRIES LTD - OTC HEALTHCARE - AUSTRALIA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 2 Australian Pharmaceutical Industries Ltd: Key Facts
- Summary 3 Australian Pharmaceutical Industries Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- BLACKMORES LTD - OTC HEALTHCARE - AUSTRALIA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 4 Blackmores Ltd: Key Facts
- Summary 5 Blackmores Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- Summary 6 Blackmores Ltd: Production Statistics 2006
- COMPETITIVE POSITIONING
- Summary 7 Blackmores Ltd: Competitive Position 2006
- MANNATECH AUSTRALIA PTY LTD - OTC HEALTHCARE - AUSTRALIA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 8 Mannatech Australia Pty Ltd: Key Facts
- Summary 9 Mannatech Australia Pty Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 10 Mannatech Australia Pty Ltd: Competitive Position 2006
- SIGMA PHARMACEUTICALS LTD - OTC HEALTHCARE - AUSTRALIA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 11 Sigma Pharmaceuticals Pty Ltd: Key Facts
- Summary 12 Sigma Pharmaceuticals Pty Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- Summary 13 Sigma Pharmaceuticals Pty Ltd: Production Statistics 2006
- COMPETITIVE POSITIONING
- Summary 14 Sigma Pharmaceuticals Pty Ltd: Competitive Position 2006
- SYMBION HEALTH LTD - OTC HEALTHCARE - AUSTRALIA
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 15 Symbion Health Ltd: Key Facts
- Summary 16 Symbion Health Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- Summary 17 Symbion Health Ltd: Production Statistics 2006
- COMPETITIVE POSITIONING
- Summary 18 Symbion Health Ltd: Competitive Position 2006
- ANALGESICS IN AUSTRALIA
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 12 Sales of Analgesics by Subsector: Value 2001-2006
- Table 13 Sales of Analgesics by Subsector: % Value Growth 2001-2006
- Table 14 Herbal vs Standard Topical Analgesics 2001/2006
- Table 15 Analgesics Company Shares by Retail Value 2002-2006
- Table 16 Analgesics Brand Shares by Retail Value 2003-2006
- Table 17 Forecast Sales of Analgesics by Subsector: Value 2006-2011
- Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN
- AUSTRALIA
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
- Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
- Table 21 Sales of Decongestants by Type: Value 2001-2006
- Table 22 Sales of Decongestants by Type: % Value Growth 2001-2006
- Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
- Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
- Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
- Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
- Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
- Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
- Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
- DIGESTIVE REMEDIES IN AUSTRALIA
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 30 Sales of Digestive Remedies by Subsector: Value 2001-2006
- Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
- Table 32 Herbal vs Standard Digestive Remedies 2001/2006
- Table 33 Digestive Remedies Company Shares by Retail Value 2002-2006
- Table 34 Digestive Remedies Brand Shares by Retail Value 2003-2006
- Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
- Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
- MEDICATED SKIN CARE IN AUSTRALIA
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 37 Sales of Medicated Skin Care by Subsector: Value 2001-2006
- Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
- Table 39 Herbal vs Standard Medicated Skin Care 2001/2006
- Table 40 Medicated Skin Care Company Shares by Retail Value 2002-2006
- Table 41 Medicated Skin Care Brand Shares by Retail Value 2003-2006
- Table 42 Acne Treatments Brand Shares by Retail Value 2003-2006
- Table 43 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
- Table 44 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
- Table 45 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
- VITAMINS AND DIETARY SUPPLEMENTS IN AUSTRALIA
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 46 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
- Table 47 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
- Table 48 Sales of Vitamins by Type: Value 2001-2006
- Table 49 Sales of Vitamins by Type: % Value Growth 2001-2006
- Table 50 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
- Table 51 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
- Table 52 Vitamins Brand Shares by Retail Value 2003-2006
- Table 53 Sales of Dietary Supplements by Type: Value 2001-2006
- Table 54 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
- Table 55 Dietary Supplements Brand Shares by Retail Value 2003-2006
- Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
- Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
- NRT SMOKING CESSATION AIDS IN AUSTRALIA
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR INDICATORS
- Table 58 Number of Smokers by Gender 2001-2006
- Table 59 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
- Table 60 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
- Table 61 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
- Table 62 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
- Table 63 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
- Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
- EYE CARE IN AUSTRALIA
- OVERVIEW
- SECTOR DATA
- Table 65 Sales of Eye Care by Subsector: Value 2001-2006
- Table 66 Sales of Eye Care by Subsector: % Value Growth 2001-2006
- Table 67 Eye Care Company Shares by Retail Value 2002-2006
- Table 68 Eye Care Brand Shares by Retail Value 2003-2006
- Table 69 Forecast Sales of Eye Care by Subsector: Value 2006-2011
- Table 70 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
- EAR CARE IN AUSTRALIA
- OVERVIEW
- ADULT MOUTHCARE IN AUSTRALIA
- OVERVIEW
- CALMING AND SLEEPING PRODUCTS IN AUSTRALIA
- OVERVIEW
- WOUND TREATMENTS IN AUSTRALIA
- OVERVIEW
- SECTOR DATA
- Table 71 Sales of Wound Treatments by Subsector: Value 2001-2006
- Table 72 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
- Table 73 Wound Treatments Company Shares by Retail Value 2002-2006
- Table 74 Wound Treatments Brand Shares by Retail Value 2003-2006
- Table 75 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
- Table 76 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
- OTC OBESITY IN AUSTRALIA
- OVERVIEW
- SECTOR DATA
- Table 77 Sales of OTC Obesity by Subsector: Value 2004-2006
- Table 78 Sales of OTC Obesity by Subsector: % Value Growth 2004-2006
- Table 79 Forecast Sales of OTC Obesity by Subsector: Value 2006-2011
- Table 80 Forecast Sales of OTC Obesity by Subsector: % Value Growth 2006-2011
- EMERGENCY CONTRACEPTION IN AUSTRALIA
- OVERVIEW
- SECTOR DATA
- Table 81 Sales of Emergency Contraception by Subsector: Value 2001-2006
- Table 82 Sales of Emergency Contraception by Subsector: % Value Growth 2001-2006
- Table 83 Forecast Sales of Emergency Contraception by Subsector: Value 2006-2011
- Table 84 Forecast Sales of Emergency Contraception by Subsector: % Value Growth 2006-2011
